Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Should cannabis for sleep apnoea be used only when CPAP fails? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Continuous positive airway pressure (CPAP) remains the first-line treatment for obstructive sleep apnoea (OSA) , but some patients struggle with adherence or experience limited benefit. This has sparked interest in cannabis in CPAP failure, a potential second-line option. Exploring second-line OSA, cannabis strategies helps patients and clinicians determine when cannabinoids may be appropriate, particularly in cases where cannabis after CPAP could provide symptom relief. 

Am I eligible for medical cannabis for pain relief?

Considering Cannabis After CPAP 

Before examining specific approaches, it is important to note that cannabis in CPAP failure is still experimental. Clinicians emphasise careful evaluation to ensure that cannabinoids are used safely and effectively alongside or after standard therapies. 

Adjunct for non-responders 

Patients who cannot tolerate CPAP may benefit from targeted symptom management. Using cannabis in CPAP failure as an adjunct can help improve sleep quality while maintaining other lifestyle or medical interventions. 

Symptom-focused support 

Cannabis may help with daytime fatigue, mild sleep disruption, or inflammation. Thoughtful cannabis after CPAP can provide relief without replacing core treatments entirely. 

Evidence-driven caution 

Healthcare providers stress that any use of cannabinoids should be guided by monitoring and clinical oversight. Second-line OSA and cannabis strategies should be considered only after evaluating risks and potential benefits. 

In summary, cannabis in CPAP failure may offer supportive benefits for certain patients, but it should always be integrated cautiously within a structured treatment plan. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories